Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2012
10/03/2012EP2505198A1 Compounds for use as therapeutic agents affecting p53 expression and/or activity
10/03/2012EP2504330A1 Amino heteroaryl compounds as beta-secretase modulators and methods of use
10/03/2012EP2504328A1 Novel compounds as receptor modulators with therapeutic utility
10/03/2012EP2504317A1 Potassium channel modulators
10/03/2012EP2504316A1 Heterocylic compounds as antagonists of the orexin receptors
10/03/2012EP2504315A1 Amino heteroaryl compounds as beta-secretase modulators and methods of use
10/03/2012CN102712626A Piperazine compound having a PGDS inhibitory effect
10/03/2012CN102712625A Nitrogen-containing heteroaryl derivatives
10/03/2012CN102712624A Indole compound and pharmaceutical use thereof
10/03/2012CN102712623A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
10/03/2012CN102712622A Indole derivative modulators of the alpha 7 nAChR
10/03/2012CN102712621A Pyrazine derivatives and their use in the treatment of neurological disorders
10/03/2012CN102712620A 4-phenoxy-nicotinamide or 4-phenoxy-pyrimidine-5-carboxamide compounds
10/03/2012CN102712619A 5-hydroxypyrimidine-4-carboxamide derivative
10/03/2012CN102712618A Novel compounds as receptor modulators with therapeutic utility
10/03/2012CN102712601A A compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent
10/03/2012CN102712597A Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents
10/03/2012CN102712596A New secondary 8-hydroxyquinoline-7-carboxamide derivatives
10/03/2012CN102712595A Novel compositions for reducing A beta 42 production and their use in treating alzheimer's disease (AD)
10/03/2012CN102712592A Novel cationic aminopyridines, dye composition comprising a cationic aminopyridine, processes therefor and uses thereof
10/03/2012CN102712589A Aryl-pyridine derivatives as aldosterone synthase inhibitors
10/03/2012CN102712587A Novel ethane diamine hepcidin antagonists
10/03/2012CN102702174A Method for preparing light stabilizer tri(1-cyclohexyloxy-2,2,6,6-tetramethyl-4-oxy-piperidyl)-1,3,5-triazine
10/03/2012CN102702173A Method for preparing sulfur ether intermediates of proton pump inhibitor
10/03/2012CN102702172A Esomeprazole sodium preparation method
10/03/2012CN102702171A Process for producing acid adduct salt of polyacidic base compound
10/03/2012CN102702170A Compounds for detecting content of micro magnesium ions and application thereof
10/03/2012CN102702169A Method for preparing light stabilizer 3-dodecyl-1(1,2,2,6,6-pentamethyl piperidyl)-2,5-dipyrrolidone
10/03/2012CN102702082A Process for the preparation of 2-substituted-5-(1-alkylthio) alkylpyridines
10/03/2012CN102702068A 3-pyrrolo-cyclohexylidene-2-dihydroindolone derivative, and application of 3-pyrrolo-cyclohexylidene-2-dihydroindolone derivative
10/03/2012CN101863844B Synthesis method of 6,7-substituted-4-aniline quinazoline
10/03/2012CN101812052B Quinoline carboxylic acid derivative containing isatin substitute and preparation method thereof
10/03/2012CN101687801B Ethers of naphtalene carboxylic acid amides as cancer cure
10/03/2012CN101490000B 2-arylindole derivatives as NPGES-1inhibitors
10/03/2012CN101351456B Isoxazolines for controlling invertebrate pests
10/02/2012US8278455 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
10/02/2012US8278454 Process for preparing tetrahydroquinoline derivatives
10/02/2012US8278453 Quinolizidinone M1 receptor positive allosteric modulators
10/02/2012US8278446 reacting 4-amino-6-chloro-pyrimidine-5-carbaldehyde with 4-benzyloxy-3-chloro-phenylamine in an aqueous solvent and a catalytic amount of hydrochloric acid, to providw 4-amino-6-(4-benzyloxy-3-chloro-phenylamino)-pyrimidine-5-carbaldehyde, then oximination with (2-morpholin-4-yl-ethyl)-hydroxylamine
10/02/2012US8278334 Cyclic amine BACE-1 inhibitors having a benzamide substituent
10/02/2012US8278329 Antagonizing N-type calcium channels; use as analgesic, neurodegenerative diseases, brain injury, bronchial asthma, unstable angina and irritable colitis, drug withdrawal symptoms; t-butyl 2-[4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-piperidinyl]-2-oxoethylcarbamate for example
10/02/2012US8278328 Compounds which have activity at M1 receptor and their uses in medicine
10/02/2012US8278325 Nitrogen-containing heteroaryl compounds and methods of use thereof
10/02/2012US8278318 Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1
10/02/2012US8278317 Potassium channel inhibitors
10/02/2012US8278314 Quinazoline analogs as receptor tyrosine kinase inhibitors
10/02/2012US8278310 Amine salts of a CRTH2 antagonist
10/02/2012US8278306 C-met protein kinase inhibitors
10/02/2012US8278304 Substituted 4-hydroxypyrimidine-5-carboxamides
10/02/2012US8278302 Substituted piperidines as CCR3 antagonists
10/02/2012US8278084 Aminopyridine dimer compounds, compositions and related methods for neuronal nitric oxide synthase inhibition
10/02/2012US8277957 Quinoxaline derivatives and organic light-emitting diodes comprising the same
10/02/2012CA2690953C Benzimidazole derivatives
10/02/2012CA2575720C Pyrimidine derivatives
10/02/2012CA2557752C Hydroxy-6-heteroaryl-phenanthridines and their use as pde4 inhibitors
10/02/2012CA2557115C Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors
10/02/2012CA2556390C 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
10/02/2012CA2546300C 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
10/02/2012CA2529453C Pyrrolidin-1,2-dicarboxylic acid-1-[(4-ethinyl-phenyl)-amide]-2-[(phenyl)-amide] derivative as inhibitors of coagulation factors xa and viia for the treatment of thromboses
10/02/2012CA2511613C Phosphonooxy quinazoline derivatives and their pharmaceutical use
09/2012
09/27/2012WO2012129491A1 Trpv3 modulators
09/27/2012WO2012129452A2 Propynoic acid carbamoyl methyl-almides and pharmaceutical compositions and methods based thereon
09/27/2012WO2012129074A1 Pyrimidine cyclohexyl glucocorticoid receptor modulators
09/27/2012WO2012128512A2 Cobalt-based compound for a solar cell
09/27/2012WO2012127302A1 Acid addition salts of (3,5-bis trifluoromethyl)-n-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2ylamino)-phenyl]-benzamide
09/27/2012WO2012127175A1 Grafted dinuclear metal complexes, and use thereof as cellular microparticle sensors
09/27/2012WO2012126922A1 Heterocyclic amine derivatives
09/27/2012WO2012126766A1 N-(3-carbamoylphenyl)-1h-pyrazole-5-carboxamide derivatives and the use thereof for controlling animal pests
09/27/2012WO2012126275A1 Spiro-containing dihydropyrazole compounds
09/27/2012WO2012065963A3 Antiviral condensed heterocyclic compounds
09/27/2012WO2012059442A3 Neurotrypsin inhibitors
09/27/2012WO2012030927A3 Modified-release dosage forms of 5-ht2c agonists useful for weight management
09/27/2012US20120245358 Process for the preparation of a compound useful as an inhibitor of tafia
09/27/2012US20120245357 Alr2 inhibitors and their synthesis from a natural source
09/27/2012US20120245348 New Cyclopentadienyl, Indenyl or Fluorenyl Substituted Phosphine Compounds and their Use in Catalytic Reactions
09/27/2012US20120245344 Gpr119 agonist
09/27/2012US20120245341 Aromatic compound, modification carrier that uses same and is used for synthesizing an oligonucleotide derivative, oligonucleotide derivative, and oligonucleotide construct
09/27/2012US20120245191 New azaspirodecanone compounds
09/27/2012US20120245185 Aryl and heteroaryl sulfones as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
09/27/2012US20120245176 Novel piperazine analogs with substituted heteroaryl groups as broad-spectrum influenza antivirals
09/27/2012US20120245172 Heterocyclic amine derivatives
09/27/2012US20120245161 Indolyl-piperidinyl benzylamines as beta-tryptase inhibitors
09/27/2012US20120245153 Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
09/27/2012US20120245150 NOVEL (HETEROCYCLE/TETRAHYDROPYRIDINE)-(PIPERAZINYL)-1-ALCANONE AND (HETEROCYCLE/DIHYDROPYRROLIDINE)-(PIPERAZINYL)-1-ALCANONE DERIVATIVES, AND USE THEREOF AS p75 INHIBITORS
09/27/2012US20120245148 Tetrahydroquinoxaline uera derivatives, their preparation and their therapeutic application
09/27/2012US20120245143 3-0x0-2,3-dihydro-1h-isoindole-4-carboxamides with selective parp-1 inhibition
09/27/2012US20120245142 3-oxo-2,3-dihydro-1h-isoindole-4-carboxamides as parp inhibitors
09/27/2012US20120245138 N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl arylsulfonamides
09/27/2012US20120245125 Pyridazine compounds, compositions and methods
09/27/2012US20120245124 TRPV3 Modulators
09/27/2012US20120244074 Labelled integrin binders
09/27/2012CA2830756A1 Grafted dinuclear metal complexes, and use thereof as cellular microparticle sensors
09/27/2012CA2830411A1 Pyrimidine cyclohexyl glucocorticoid receptor modulators
09/27/2012CA2830117A1 N-(3-carbamoylphenyl)-1h-pyrazole-5-carboxamide derivatives and the use thereof for controlling animal pests
09/27/2012CA2828283A1 Heterocyclic amine derivatives
09/26/2012EP2502914A2 Modulators of ATP-binding cassette transporters
09/26/2012EP2502912A2 Modulators of ATP-binding cassette transporters
09/26/2012EP2502911A2 Modulators of ATP-binding cassette transporters
09/26/2012EP2502909A1 Aminopyridine derivative
09/26/2012EP2501695A2 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties